Developer docs
API playgroundTry for free, no card

Search company profiles

Hanson Wade

Full company profile

uuid0006d2h

Namestring
Hanson Wade
Legal namestring
Hanson Wade
Websiteurl
hansonwade.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Hanson Wade is a London-based private life sciences information and events company that structures data, content, and expert networks around emerging and complex niches of drug discovery and development. The company operates four product lines: (1) Conferences, a portfolio of 200+ annual industry events delivering 6,600 speakers and 30,000 attendees across therapeutic topics such as ADCs, cell therapy, gene therapy, RNA therapy, protein degradation, microbiome, precision oncology, CNS, autoimmune and immunology, and process development; (2) Beacon, a proprietary life sciences data platform with 15+ specialised database modules tracking 35,000+ deals and companies, 40,000 drugs, and 70,000 clinical trials, on which 24 of the world's top 25 drug developers are documented as customers; (3) Intelligence, a bespoke market research and scientific consultancy executing over 5,000 research calls per year through a 25,000+ expert network; and (4) Searchlight, year-round expert networks including the LEAP HR life sciences and construction communities.

The core technology is a proprietary ontology layer combined with manually curated databases and a content management stack supporting the Beacon platform, conference content production, and custom market intelligence research tooling. The business generates revenue through a mix of one-time conference registrations, sponsorships, and exhibition fees; recurring annual Beacon database subscriptions sold via dedicated enterprise field sales; project-based Intelligence consulting engagements; and Searchlight membership subscriptions. Customer concentration is anchored in the top 25 global pharmaceutical and biotech companies by R&D investment, with named enterprise logos including Pfizer, Johnson & Johnson, Roche, Merck, Novartis, AstraZeneca, Eli Lilly, Moderna, and BioNTech.

The company was founded around 2013, scaled under Graphite Capital's private equity ownership from 2019, and in 2026 announced the carve-out and sale of Beacon to Corten Capital, a transaction expected to close by end of June 2026 and delivering Graphite Capital approximately 4x cash-on-cash. Headquartered at 52 Grosvenor Gardens, London, Hanson Wade employs 101-250 people and operates globally across Europe, North America, and Asia with dedicated sales functions for sponsorship, delegate, and Beacon subscription revenue.

Short descriptiontext

Hanson Wade is a London-based private company that runs 200+ annual life sciences conferences, a proprietary drug and trial database platform (Beacon), bespoke market intelligence consulting, and year-round expert networks (Searchlight) for the global biopharmaceutical industry, including all top-25 pharma companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences conferences, drug development databases, biopharma market intelligence, clinical trial analytics, pharmaceutical networking events
Industry2 codes
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYBPAHALAE
Industry & Sector Research (Syndicated/Custom)
NAICS code3 codes
  • Other Scientific and Technical Consulting Services54169
  • Marketing Research and Public Opinion Polling541910
  • Professional, Scientific, and Technical Services541
Product category
Life Sciences Events and Intelligence
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Conference Revenue
TypeOne Time License
Description

Revenue from hosting 200+ annual conferences across life sciences topics including registration fees, sponsorships, and exhibition space. Conferences curate premium content presented by world-class speakers and assemble qualified audiences for networking.

hansonwade.com
2Beacon Database Subscriptions
TypeSubscription Recurring
Description

Subscription-based access to Beacon drug and trial intelligence platform with multiple specialized modules covering ADC, Cell Therapy, Gene Therapy, RNA, Protein Degradation, Microbiome, CNS, Precision Oncology, and other therapeutic areas. Annual recurring revenue model.

hansonwade.com
3Intelligence Consultancy Services
TypeProfessional Services
Description

Custom market research and scientific intelligence services including KOL interviews, market landscape analysis, competitive profiling, brand surveys, and value proposition testing. Bespoke project-based consulting.

hansonwade.com
4Searchlight Expert Networks
TypeSubscription Recurring
Description

Year-round expert networks providing HR leaders and teams with industry-specific insights and connections through membership subscriptions.

hansonwade.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Beacon Platform Subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Annual subscription model for database access. Enterprise pricing based on organization size and module selection.

hansonwade.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Beacon
Description

World leading data analysis tool for preclinical and clinical trial information with unrivaled granularity of search function, data quality, and exhaustiveness. Tracks 35,000+ deals and companies, 40,000+ drugs, and 70,000+ trials.

hansonwade.com
+3 more records
Core offering1 text field

Hanson Wade delivers a portfolio of premium life sciences information products: 200+ niche industry conferences annually bringing together senior biopharma decision-makers around emerging therapeutic modalities; Beacon, a proprietary drug and clinical trial data platform with annual subscriptions; Intelligence, a bespoke market research and scientific consulting service; and Searchlight, year-round expert networks for life sciences HR and R&D leaders. The portfolio is anchored by proprietary ontologies, comprehensive data coverage across therapeutic areas, and a 25,000+ expert network serving top pharma and biotech companies globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 24 out of 25 top drug developers trust Beacon for drug development decisions
+2 more records
Product overview1 text field

Hanson Wade is a life sciences research and events company offering a platform-plus-modules architecture. The core portfolio consists of four main products: Conferences (200+ industry events annually with world-class speakers), Beacon (proprietary life sciences data and analytics platform with 15 specialized database modules covering drug and trial information), Intelligence (bespoke market research and scientific consulting services), and Searchlight (year-round expert networks including LEAP HR communities). The company focuses on emerging and complex niches of drug discovery and development across ten therapeutic topics: ADCs & Engineered Antibodies, Autoimmune & Immunology, Cell Therapy, CNS, Gene Therapy, Microbiome, Precision Oncology, Process Development & Manufacturing, Protein Degradation, and RNA Therapy. Beacon was recently carved out as a standalone entity under Corten Capital acquisition (expected completion June 2026).

Product and service4 records
1Conferences
CategoryIndustry Conferences and Events
Description

Hanson Wade Conferences curate premium content presented by world-class speakers and assemble like-minded communities that make meaningful connections within clearly defined niches of R&D. The portfolio delivers 200+ events annually with 6,600 speakers and 30,000 attendees across emerging therapeutic modalities including ADCs, cell therapy, gene therapy, RNA therapy, protein degradation, microbiome, precision oncology, and CNS.

2Beacon
CategoryLife Sciences Data and Intelligence Platform
Description

Beacon is the world leading data analysis tool for preclinical and clinical trial information, providing unrivaled granularity of search function, data quality, and exhaustiveness. It tracks 35,000+ deals and companies, 40,000 drugs, and 70,000 trials, and is trusted by 24 of the world's top 25 drug developers. Subscriptions are sold on an annual recurring basis with multiple specialized modules covering ADC, Cell Therapy, Gene Therapy, RNA, Protein Degradation, Microbiome, Precision Oncology, CNS, Autoimmune, Oncology, Neuroscience, and CVRM therapeutic areas.

3Intelligence
CategoryLife Sciences Market Intelligence Consulting
Description

Hanson Wade Intelligence provides precise and targeted market research and scientific intelligence custom-made for unique R&D objectives. Services include KOL interviews, market landscape analysis, competitive profiling, brand surveys, and product message testing. The team makes over 5,000 research calls into the life science industry each year, supported by an extensive network of 25,000+ drug development experts.

4Searchlight
CategoryExpert Networks and Membership Communities
Description

Searchlight by Hanson Wade is a year-round expert networks offering where group members regularly unite around highly specialized content areas and gain access to an exclusive KOL network to overcome shared drug development challenges. Includes LEAP HR: Life Sciences and LEAP HR: Construction, with 2 industry-specific expert networks, 50 member organizations, and 150 value-adds per year.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Clarivate's Cortellis and Web of Science platforms compete head-to-head with Beacon for pharma R&D intelligence budgets. Multiple Hanson Wade senior leaders joined from Clarivate/Thomson Reuters, underscoring the direct competitive overlap and product benchmark.

TypeDirect peer
Description

Citeline is the leading subscription pharma intelligence suite covering drug development, clinical trials, and regulatory intelligence — directly comparable to Beacon's coverage of 70,000+ trials, 40,000+ drugs, and company/deals data within biopharma R&D.

TypeBroad incumbent
Description

GlobalData offers syndicated and custom industry research across pharma and healthcare; Andy Cook joined Hanson Wade from GlobalData. Comparable on intelligence/research services layer of the Hanson Wade business and on industry research subscription analytics.

TypeDirect peer
Description

Oxford Global runs life sciences conferences in drug discovery and development niches that overlap with Hanson Wade's 200+ annual events. Jessica Thomson joined Hanson Wade in 2024 from Oxford Global, evidencing direct competition for sponsors, speakers, and delegates in therapeutic conferences.

TypeEmerging player
Description

Kisaco Research produces commercial life sciences conferences in similar drug-modality niches to Hanson Wade (e.g., TPD, Small Molecules, Biomarkers) and competes for sponsor and delegate spend in overlapping therapeutic areas.

TypeBroad incumbent
Description

Informa is the global events and B2B information powerhouse whose Pharma Intelligence (Citeline) and vast conference portfolio compete with both the Beacon data business and Hanson Wade's conference business at enterprise scale.

TypeDirect peer
Description

Cambridge Healthtech Institute runs established life sciences conferences in drug discovery, genomics, and bioprocessing that compete directly with Hanson Wade for sponsors and delegates across biopharma R&D niches.

8Tarsus Group
TypeDirect peer
Description

Tarsus is a B2B events organizer whose pharma and life sciences portfolio overlaps with Hanson Wade's conference business; Hanson Wade's CFO Mark Pennington joined directly from Tarsus, indicating deep familiarity between the two event portfolios.

9Elsevier / RELX (Reaxys, Embase)
TypeBroad incumbent
Description

Elsevier competes in pharma R&D data and analytics via Reaxys, Embase, and ClinicalPathway, and runs adjacent life sciences content and reference databases that overlap with Beacon's drug and trial intelligence.

TypeEmerging player
Description

BioCentury is an established life sciences intelligence and analysis provider focused on biopharma strategy and pipeline analysis; competes for the same senior R&D decision-maker audience that Beacon and Hanson Wade Intelligence serve.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers21 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hanson Wade

Life Sciences Events and Intelligencehansonwade.com

Hanson Wade is a London-based private company that runs 200+ annual life sciences conferences, a proprietary drug and trial database platform (Beacon), bespoke market intelligence consulting, and year-round expert networks (Searchlight) for the global biopharmaceutical industry, including all top-25 pharma companies.

What Hanson Wade does

Hanson Wade is a London-based private life sciences information and events company that structures data, content, and expert networks around emerging and complex niches of drug discovery and development. The company operates four product lines: (1) Conferences, a portfolio of 200+ annual industry events delivering 6,600 speakers and 30,000 attendees across therapeutic topics such as ADCs, cell therapy, gene therapy, RNA therapy, protein degradation, microbiome, precision oncology, CNS, autoimmune and immunology, and process development; (2) Beacon, a proprietary life sciences data platform with 15+ specialised database modules tracking 35,000+ deals and companies, 40,000 drugs, and 70,000 clinical trials, on which 24 of the world's top 25 drug developers are documented as customers; (3) Intelligence, a bespoke market research and scientific consultancy executing over 5,000 research calls per year through a 25,000+ expert network; and (4) Searchlight, year-round expert networks including the LEAP HR life sciences and construction communities.

The core technology is a proprietary ontology layer combined with manually curated databases and a content management stack supporting the Beacon platform, conference content production, and custom market intelligence research tooling. The business generates revenue through a mix of one-time conference registrations, sponsorships, and exhibition fees; recurring annual Beacon database subscriptions sold via dedicated enterprise field sales; project-based Intelligence consulting engagements; and Searchlight membership subscriptions. Customer concentration is anchored in the top 25 global pharmaceutical and biotech companies by R&D investment, with named enterprise logos including Pfizer, Johnson & Johnson, Roche, Merck, Novartis, AstraZeneca, Eli Lilly, Moderna, and BioNTech.

The company was founded around 2013, scaled under Graphite Capital's private equity ownership from 2019, and in 2026 announced the carve-out and sale of Beacon to Corten Capital, a transaction expected to close by end of June 2026 and delivering Graphite Capital approximately 4x cash-on-cash. Headquartered at 52 Grosvenor Gardens, London, Hanson Wade employs 101-250 people and operates globally across Europe, North America, and Asia with dedicated sales functions for sponsorship, delegate, and Beacon subscription revenue.

Hanson Wade firmographics

Firmographics
Name
Hanson Wade
Legal name
Hanson Wade
Website
https://hansonwade.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
251–500 employees
Short description
Hanson Wade is a London-based private company that runs 200+ annual life sciences conferences, a proprietary drug and trial database platform (Beacon), bespoke market intelligence consulting, and year-round expert networks (Searchlight) for the global biopharmaceutical industry, including all top-25 pharma companies.
Ownership category
akta.pro rank

Hanson Wade industry classification

Industry
Product category
Life Sciences Events and Intelligence
NAICS
Other Scientific and Technical Consulting Services (54169), Marketing Research and Public Opinion Polling (541910), Professional, Scientific, and Technical Services (541)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYBPAHALAE
Industry & Sector Research (Syndicated/Custom)

Keywords

  • Life sciences conferences
  • Drug development databases
  • Biopharma market intelligence
  • Clinical trial analytics
  • Pharmaceutical networking events

Where Hanson Wade is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Hanson Wade business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Conference Revenue: Revenue from hosting 200+ annual conferences across life sciences topics including registration fees, sponsorships, and exhibition space. Conferences curate premium content presented by world-class speakers and assemble qualified audiences for networking.
  2. Beacon Database Subscriptions: Subscription-based access to Beacon drug and trial intelligence platform with multiple specialized modules covering ADC, Cell Therapy, Gene Therapy, RNA, Protein Degradation, Microbiome, CNS, Precision Oncology, and other therapeutic areas. Annual recurring revenue model.
  3. Intelligence Consultancy Services: Custom market research and scientific intelligence services including KOL interviews, market landscape analysis, competitive profiling, brand surveys, and value proposition testing. Bespoke project-based consulting.
  4. Searchlight Expert Networks: Year-round expert networks providing HR leaders and teams with industry-specific insights and connections through membership subscriptions.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualBeacon Platform Subscription

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Hanson Wade product offering

Product offering

Core offering

Hanson Wade delivers a portfolio of premium life sciences information products: 200+ niche industry conferences annually bringing together senior biopharma decision-makers around emerging therapeutic modalities; Beacon, a proprietary drug and clinical trial data platform with annual subscriptions; Intelligence, a bespoke market research and scientific consulting service; and Searchlight, year-round expert networks for life sciences HR and R&D leaders. The portfolio is anchored by proprietary ontologies, comprehensive data coverage across therapeutic areas, and a 25,000+ expert network serving top pharma and biotech companies globally.

Product overview

Hanson Wade is a life sciences research and events company offering a platform-plus-modules architecture. The core portfolio consists of four main products: Conferences (200+ industry events annually with world-class speakers), Beacon (proprietary life sciences data and analytics platform with 15 specialized database modules covering drug and trial information), Intelligence (bespoke market research and scientific consulting services), and Searchlight (year-round expert networks including LEAP HR communities). The company focuses on emerging and complex niches of drug discovery and development across ten therapeutic topics: ADCs & Engineered Antibodies, Autoimmune & Immunology, Cell Therapy, CNS, Gene Therapy, Microbiome, Precision Oncology, Process Development & Manufacturing, Protein Degradation, and RNA Therapy. Beacon was recently carved out as a standalone entity under Corten Capital acquisition (expected completion June 2026).

Differentiator

Problem solved

Functional benefit

Brands

  • Beacon: World leading data analysis tool for preclinical and clinical trial information with unrivaled granularity of search function, data quality, and exhaustiveness. Tracks 35,000+ deals and companies, 40,000+ drugs, and 70,000+ trials.
  • Conferences
  • Intelligence
  • Searchlight

Products and services

  • Conferences Hanson Wade Conferences curate premium content presented by world-class speakers and assemble like-minded communities that make meaningful connections within clearly defined niches of R&D. The portfolio delivers 200+ events annually with 6,600 speakers and 30,000 attendees across emerging therapeutic modalities including ADCs, cell therapy, gene therapy, RNA therapy, protein degradation, microbiome, precision oncology, and CNS.
  • Beacon Beacon is the world leading data analysis tool for preclinical and clinical trial information, providing unrivaled granularity of search function, data quality, and exhaustiveness. It tracks 35,000+ deals and companies, 40,000 drugs, and 70,000 trials, and is trusted by 24 of the world's top 25 drug developers. Subscriptions are sold on an annual recurring basis with multiple specialized modules covering ADC, Cell Therapy, Gene Therapy, RNA, Protein Degradation, Microbiome, Precision Oncology, CNS, Autoimmune, Oncology, Neuroscience, and CVRM therapeutic areas.
  • Intelligence Hanson Wade Intelligence provides precise and targeted market research and scientific intelligence custom-made for unique R&D objectives. Services include KOL interviews, market landscape analysis, competitive profiling, brand surveys, and product message testing. The team makes over 5,000 research calls into the life science industry each year, supported by an extensive network of 25,000+ drug development experts.
  • Searchlight Searchlight by Hanson Wade is a year-round expert networks offering where group members regularly unite around highly specialized content areas and gain access to an exclusive KOL network to overcome shared drug development challenges. Includes LEAP HR: Life Sciences and LEAP HR: Construction, with 2 industry-specific expert networks, 50 member organizations, and 150 value-adds per year.

Quantifiable outcome

  • 24 out of 25 top drug developers trust Beacon for drug development decisions
  • +2 more outcomes

Companies that use Hanson Wade

Customer profile

Named customers21 records

Segments4 records

Ideal customer profiles3 records

Hanson Wade technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Hanson Wade partnerships and signals

Strategic signal

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Hanson Wade competitors and assessment

Company assessment

Direct peers

  • Clarivate (Cortellis): Clarivate's Cortellis and Web of Science platforms compete head-to-head with Beacon for pharma R&D intelligence budgets. Multiple Hanson Wade senior leaders joined from Clarivate/Thomson Reuters, underscoring the direct competitive overlap and product benchmark.
  • Citeline (Informa Pharma Intelligence): Citeline is the leading subscription pharma intelligence suite covering drug development, clinical trials, and regulatory intelligence — directly comparable to Beacon's coverage of 70,000+ trials, 40,000+ drugs, and company/deals data within biopharma R&D.
  • Oxford Global: Oxford Global runs life sciences conferences in drug discovery and development niches that overlap with Hanson Wade's 200+ annual events. Jessica Thomson joined Hanson Wade in 2024 from Oxford Global, evidencing direct competition for sponsors, speakers, and delegates in therapeutic conferences.
  • Cambridge Healthtech Institute: Cambridge Healthtech Institute runs established life sciences conferences in drug discovery, genomics, and bioprocessing that compete directly with Hanson Wade for sponsors and delegates across biopharma R&D niches.
  • Tarsus Group: Tarsus is a B2B events organizer whose pharma and life sciences portfolio overlaps with Hanson Wade's conference business; Hanson Wade's CFO Mark Pennington joined directly from Tarsus, indicating deep familiarity between the two event portfolios.

Broad incumbents

  • GlobalData: GlobalData offers syndicated and custom industry research across pharma and healthcare; Andy Cook joined Hanson Wade from GlobalData. Comparable on intelligence/research services layer of the Hanson Wade business and on industry research subscription analytics.
  • Informa (Pharma & Life Sciences Division): Informa is the global events and B2B information powerhouse whose Pharma Intelligence (Citeline) and vast conference portfolio compete with both the Beacon data business and Hanson Wade's conference business at enterprise scale.
  • Elsevier / RELX (Reaxys, Embase): Elsevier competes in pharma R&D data and analytics via Reaxys, Embase, and ClinicalPathway, and runs adjacent life sciences content and reference databases that overlap with Beacon's drug and trial intelligence.

Emerging players

  • Kisaco Research: Kisaco Research produces commercial life sciences conferences in similar drug-modality niches to Hanson Wade (e.g., TPD, Small Molecules, Biomarkers) and competes for sponsor and delegate spend in overlapping therapeutic areas.
  • BioCentury: BioCentury is an established life sciences intelligence and analysis provider focused on biopharma strategy and pipeline analysis; competes for the same senior R&D decision-maker audience that Beacon and Hanson Wade Intelligence serve.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Hanson Wade social profiles

Digital presence

Hanson Wade financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hanson Wade leadership team

Management profile

Number of profiles

Profiles12 records

Hanson Wade subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Hanson Wade funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hanson Wade M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hanson Wade

What does Hanson Wade do?

Hanson Wade delivers a portfolio of premium life sciences information products: 200+ niche industry conferences annually bringing together senior biopharma decision-makers around emerging therapeutic modalities; Beacon, a proprietary drug and clinical trial data platform with annual subscriptions; Intelligence, a bespoke market research and scientific consulting service; and Searchlight, year-round expert networks for life sciences HR and R&D leaders. The portfolio is anchored by proprietary ontologies, comprehensive data coverage across therapeutic areas, and a 25,000+ expert network serving top pharma and biotech companies globally.

Is Hanson Wade a public or private company?

Hanson Wade is a private company. It is classified as private equity controlled and is currently operating.

When was Hanson Wade founded?

Hanson Wade was founded in 2013. It employs 251 to 500 people.

Where is Hanson Wade based?

Hanson Wade is headquartered in London, United Kingdom, in the Europe region.

How does Hanson Wade make money?

Four revenue lines are on record. Conference Revenue is the primary driver. The others are beacon Database Subscriptions, intelligence Consultancy Services and searchlight Expert Networks.

Who are Hanson Wade's main competitors?

Direct peers on record are Clarivate (Cortellis), Citeline (Informa Pharma Intelligence), Oxford Global, Cambridge Healthtech Institute and Tarsus Group. Broad incumbents are GlobalData, Informa (Pharma & Life Sciences Division) and Elsevier / RELX (Reaxys, Embase). Emerging players are Kisaco Research and BioCentury.

Does Hanson Wade have an API?

No public API is recorded for Hanson Wade.

What industry is Hanson Wade in?

Hanson Wade's product category is Life Sciences Events and Intelligence. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of BPAHALAE, Industry & Sector Research (Syndicated/Custom). Its NAICS code is 54169.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MorningstarAllerGene AI Therapeutics Founder and CEO Sid Kerkar to Present In Vivo Mast Cell-Targeting CAR Technology at Hanson Wade SummitAllerGene AI Therapeutics announced that its Founder and CEO, Sid Kerkar, will present the company's in vivo mRNA-LNP CAR-T technology at the Hanson Wade Summit in Boston from July 28 to 30, 2026. The presentation highlights a first-in-class approach designed to selectively target disease-driving mast cells as a potential treatment for conditions such as mastocytosis, chronic urticaria, and severe allergies. AllerGene aims to demonstrate the scalability of this off-the-shelf therapeutic platform as part of its roadmap toward first-in-human studies.BioSpaceAllerGene AI Therapeutics Founder and CEO Sid Kerkar to Present In Vivo Mast Cell-Targeting CAR Technology at Hanson Wade SummitAllerGene AI Therapeutics CEO Sid Kerkar will present in vivo mRNA-LNP CAR-T technology targeting mast cells at the Hanson Wade summit in Boston, July 28-30, 2026. The presentation outlines a first-in-class approach to selectively eliminate disease-driving mast cells for conditions like mastocytosis and anaphylaxis. The company aims to advance toward first-in-human studies.PR NewswireAllerGene AI Therapeutics Founder and CEO Sid Kerkar to Present In Vivo Mast Cell-Targeting CAR Technology at Hanson Wade SummitAllerGene AI Therapeutics CEO Sid Kerkar will present its in vivo mRNA-LNP CAR-T technology targeting mast cells at the Hanson Wade summit in Boston on July 30, 2026. The company aims to develop a scalable, off-the-shelf platform to selectively eliminate disease-driving mast cells for conditions like mastocytosis and anaphylaxis.HrtodayCarol Cairnes Appointed as Head of HR Operations at Hanson Wade GroupCarol Cairnes has been appointed as Head of HR Operations at Hanson Wade Group, bringing over two decades of HR leadership experience across hospitality, retail, and global service organizations. In her new role, she will lead enterprise-wide people operations strategy, governance, and workforce experience for hybrid and international teams as the company continues its expansion. Prior to joining Hanson Wade, Cairnes spent over sixteen years at D&D London in progressive leadership roles overseeing people strategy for Europe and the United States.Translational-Digital-Pathology-Ai2nd Translational Digital Pathology & AIThe article is a promotional overview for the 2nd Translational Digital Pathology & AI Summit, highlighting partnership opportunities between biopharma leaders and digital pathology technology providers. It outlines how the event facilitates networking to advance R&D, clinical programs, and diagnostic accuracy through AI and image analysis solutions. The text serves as a call to action for companies to sponsor or exhibit at the conference organized by Hanson Wade.Innovation-Obesity-SummitUnlocking Obesity with Precision Medicine Powered by Genomics & Real-World DataThe article outlines a session at an event organized by Hanson Wade regarding the use of precision medicine for obesity treatment. It details the establishment of a longitudinal clinical dataset integrating multi-omics and real-world data for patients treated with GLP-1R agonists. The initiative aims to differentiate data utility and generate translational insights for research and development.Dry-Amd-Therapeutics6th Dry AMD & GA Therapeutics Development SummitHanson Wade is organizing the 6th Dry AMD & GA Therapeutics Development Summit in 2025 to facilitate partnerships between biotech and pharma companies and service providers. The event aims to connect industry leaders with experts in ophthalmic clinical trials, ocular delivery platforms, and imaging technologies to advance retinal therapies.GlobeNewswireFoghorn Therapeutics to Present at Hanson Wade's 5th Annual Targeted Protein Degradation SummitFoghorn Therapeutics will present new data at Hanson Wade's 5th Annual Targeted Protein Degradation Summit in Danvers, Mass., Oct. 25-28, 2022. The company will present initial pharmacodynamic data from its Phase 1 study of FHD-609, a BRD9 degrader for synovial sarcoma and SMARCB1-loss tumors, and discuss CMC development considerations.GlobeNewswireAnima Biotech to Present at Hanson Wade 3rd Annual RAS/MAPK Pathway Targeted Drug Discovery SummitAnima Biotech will present at the 3rd annual RAS/MAPK pathway targeted drug discovery summit hosted by Hanson Wade, held virtually February 22-24, 2022. Co-founder and CIO Iris Alroy will present on pan-KRAS mRNA translation modulators in mKRAS-driven tumors, followed by a Q&A session.